Entry |
|
Name |
Mutation-inactivated MEN1 to transcription
|
Definition |
(MEN1*+KMT2A) // (CDKN1B,CDKN2C) |
Expanded |
(4221v1+4297) // (1027,1031) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00247 | Multiple endocrine neoplasia syndrome |
H00246 | Primary hyperparathyroidism |
H01522 | Zollinger-Ellison syndrome |
|
Gene |
4297 | KMT2A; lysine methyltransferase 2A |
1027 | CDKN1B; cyclin dependent kinase inhibitor 1B |
1031 | CDKN2C; cyclin dependent kinase inhibitor 2C |
|
Variant |
|
Reference |
|
Authors |
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P |
Title |
Genetic mutations in sporadic pituitary adenomas--what to screen for? |
Journal |
|
Reference |
|
Authors |
Wu X, Hua X |
Title |
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective. |
Journal |
|
Reference |
|
Authors |
Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL |
Title |
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. |
Journal |
|
Reference |
|
Authors |
Tsukada T, Nagamura Y, Ohkura N |
Title |
MEN1 gene and its mutations: basic and clinical implications. |
Journal |
|
LinkDB |
|